I now have comprehensive information to give a thorough, well-referenced answer. Let me compile the full response.
Clinical Analysis: 60-Year-Old Male with Chronic Bloody Mucus Diarrhea + Left-Sided Colitis + Pangastritis
Most Likely Diagnosis
The clinical picture strongly points to Ulcerative Colitis (UC) - specifically left-sided UC (distal colitis), with the gastric findings representing upper GI involvement, which can occur in IBD (more commonly in Crohn's disease but also in UC as "IBD-associated gastritis" or "backwash" equivalent).
Key clinical pointers in this case:
- Chronic bloody + mucus diarrhea for >10 years
-
5 episodes/day (fulfills "moderate disease" criteria per Rosen's: >4 stools/day)
- Left-sided colitis on colonoscopy - consistent with UC pattern (rectum extending proximally in a continuous fashion)
- Moderate pangastritis on endoscopy - raises the possibility of Crohn's disease (which can involve the entire GI tract from esophagus to anus) or IBD-associated gastritis
Differential Diagnosis to Consider
| Condition | Supporting Features | Against |
|---|
| Ulcerative Colitis (Left-sided) | Continuous mucosal inflammation, left-sided, bloody mucus diarrhea, chronic course | Gastric involvement (rare but described) |
| Crohn's Disease (Colonic ± upper GI) | Pangastritis (upper GI involvement), chronic course, mucus | Typically skip lesions, UC pattern was "left-sided colitis" |
| Infectious Colitis (chronic) | Bloody diarrhea, mucus | Typically self-limiting, not 10+ years |
| Ischemic Colitis | Left-sided distribution (splenic flexure, sigmoid) | Age could fit, but not 10-year chronic course |
| Microscopic Colitis | Chronic watery diarrhea, older age | Usually watery, not bloody |
| Colorectal Cancer | Age 60, chronic colitis raises risk | Not primary cause; complication to screen for |
The combination of pangastritis + left-sided colitis in a 10-year course is most suspicious for Crohn's disease affecting both upper GI and colon, or UC with concomitant H. pylori/NSAID gastritis.
Workup Plan (Systematic Approach)
1. History Refinement
- Nature of stool: blood mixed vs. coating, presence of pus
- Nocturnal diarrhea (suggests IBD > IBS)
- Abdominal pain: perianal disease, fistulae, fissures (points to Crohn's)
- Weight loss, fever, fatigue
- Family history of IBD or colorectal cancer
- Medication history: NSAIDs (can worsen/cause gastritis and colitis), aspirin, steroids
- Travel history, antibiotic use (C. difficile risk)
- Extraintestinal symptoms: joint pain, eye redness, skin lesions, jaundice
2. Physical Examination
- Nutritional status, BMI, signs of malnutrition
- Abdominal tenderness (location tells you disease location)
- Perianal inspection: fissures, fistulae, skin tags (strongly suggests Crohn's)
- Oral ulcers (Crohn's)
- Skin: erythema nodosum, pyoderma gangrenosum
- Eyes: episcleritis, uveitis
- Joints: arthropathy
3. Laboratory Investigations
Blood tests:
- CBC - assess for anemia (iron deficiency from chronic blood loss, B12/folate deficiency), leukocytosis (active disease)
- ESR, CRP - inflammatory markers, monitor disease activity
- Serum albumin - marker of nutritional status and disease severity
- LFTs - screen for primary sclerosing cholangitis (PSC, occurs in 2-7.5% of IBD patients, especially UC)
- Iron studies (serum iron, TIBC, ferritin) - iron deficiency anemia
- Serum B12, folate - if extensive small bowel involvement
- Renal function - baseline
Serologic markers (to differentiate UC vs. Crohn's):
- pANCA (perinuclear antineutrophil cytoplasmic antibody) - positive in ~55% of UC patients
- ASCA (anti-Saccharomyces cerevisiae antibody IgG + IgA) - elevated in 40-70% of Crohn's disease; <15% of UC
- ASCA-positive + pANCA-negative = 55% sensitivity, 93% specificity for Crohn's disease
- Anti-OmpC, anti-CBir1, anti-I2 - associated with Crohn's
Note: Serologic markers support but cannot independently diagnose IBD.
Stool tests:
- Stool culture - rule out infectious colitis (Salmonella, Shigella, Campylobacter, E. coli O157)
- Stool for ova and parasites - Entamoeba histolytica, Giardia
- C. difficile toxin PCR - especially if any antibiotic history
- Fecal calprotectin - elevated in active IBD; useful to monitor disease activity and remission (lower in remission)
- Fecal lactoferrin - marker of intestinal inflammation
4. Endoscopy + Histology (Most Important)
Repeat Colonoscopy with biopsies:
- Assess current extent of disease (it can extend over time - 10-15% of initially left-sided UC progress to pancolitis over 10 years)
- Look for continuous vs. skip lesions (UC = continuous; Crohn's = skip)
- Assess rectal involvement (UC always starts in rectum)
- Biopsies from multiple sites (right colon, transverse, left colon, rectum) - look for:
- Crypt distortion, crypt abscesses, basal plasmacytosis (chronic colitis)
- Granulomas (pathognomonic for Crohn's if present)
- Dysplasia (cancer surveillance after 10 years of colitis - this patient is at risk!)
Repeat Upper GI Endoscopy + biopsies:
- Re-assess pangastritis
- Biopsy for H. pylori (CLO test + histology)
- Look for granulomas in gastric/duodenal biopsies (if present, strongly supports Crohn's disease)
- Evaluate duodenum for Crohn's involvement
Important: After 8-10 years of left-sided UC, dysplasia/colorectal cancer surveillance colonoscopy is mandatory. Risk of CRC increases significantly after 10 years.
5. Imaging
- CT enterography or MRI enterography - to evaluate small bowel for Crohn's involvement (strictures, fistulae, skip lesions), which cannot be seen on colonoscopy
- CT abdomen/pelvis - if complications suspected (abscess, perforation, stricture)
- Barium studies have been largely supplanted by CT/MRI enterography
6. Additional Tests Based on Findings
- Bone density (DEXA scan) - if on long-term steroids; IBD patients are at risk for osteoporosis
- Hepatobiliary workup (MRCP if LFTs abnormal) - for primary sclerosing cholangitis
- Colonoscopy + chromoendoscopy - if dysplasia surveillance is needed (standard of care after 10 years of colitis)
Disease Activity Severity Classification (Rosen's Emergency Medicine)
| Severity | Criteria |
|---|
| Mild UC | <4 stools/day, may have some blood, no systemic toxicity |
| Moderate UC | >4 stools/day, minimal signs of toxicity |
| Severe UC | >6 bloody stools/day + systemic toxicity (fever, tachycardia, anemia, elevated ESR) |
This patient's >5 episodes/day with bloody mucus = moderate disease.
Key Differentiating Point: UC vs. Crohn's
| Feature | Crohn's Disease | Ulcerative Colitis |
|---|
| GI involvement | Entire GI tract (esophagus to anus) | Colon only |
| Pattern | Skip lesions | Continuous from rectum |
| Transmural inflammation | Yes | No (superficial) |
| Fistulae/abscesses | Yes | No |
| Perianal disease | Yes | No |
| pANCA | 20% | 55% |
| ASCA | 40-70% | <15% |
| Granulomas on biopsy | Yes (pathognomonic) | No |
The pangastritis is the key clue here - if biopsies from the stomach show granulomas, this shifts the diagnosis firmly to Crohn's disease.
Cancer Surveillance Note
This patient has had left-sided colitis for >10 years - this puts him in the category requiring surveillance colonoscopy for colorectal cancer, as the risk of CRC increases significantly after 8-10 years of IBD. Per guidelines, he should undergo chromoendoscopy with targeted biopsies or systematic biopsy surveillance.
Sources:
- Goldman-Cecil Medicine, 26th ed. (Ulcerative Colitis - Diagnosis, Laboratory Findings, Serologic Markers)
- Rosen's Emergency Medicine, 9th ed. (IBD - Clinical Features, Severity Classification)
- Yamada's Textbook of Gastroenterology, 7th ed. (Left-sided UC - Treatment)
- ACG Clinical Guideline Update: Ulcerative Colitis in Adults, 2025 [PMID: 40701556]
- AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe UC, 2024 [PMID: 39572132]